Epidemiology of Respiratory Syncytial Virus in a Large Pediatric Hospital in Central Italy and Development of a Forecasting Model to Predict the Seasonal Peak

Overview

Journal Ital J Pediatr

Publisher Biomed Central

Specialty Pediatrics

Date 2024 Apr 8

PMID 38589886

Authors

Renato Cutrera

Marta Luisa Ciofi Degli Atti

Andrea Dotta

Carmen DAmore

Lucilla Rava

Carlo Federico Perno

Alberto Villani

Affiliations

Soon will be listed here.

Abstract

Background: Respiratory Syncytial Virus (RSV) is responsible for the majority of acute lower respiratory infections in infants and can affect also older age groups. Restrictions linked to the emergence of the SARS-CoV-2 pandemic and their subsequent lifting caused a change in the dynamics of RSV circulation. It is therefore fundamental to monitor RSV seasonal trends and to be able to predict its seasonal peak to be prepared to the next RSV epidemics.

Methods: We performed a retrospective descriptive study on laboratory-confirmed RSV infections from Bambino Gesù Children's Hospital in Rome from 1st January 2018 to 31st December 2022. Data on RSV-positive respiratory samples (n = 3,536) and RSV-confirmed hospitalizations (n = 1,895) on patients aged 0-18 years were analyzed. In addition to this, a SARIMA (Seasonal AutoRegressive Integrated Moving Average) forecasting model was developed to predict the next peak of RSV.

Results: Findings show that, after the 2020 SARS-CoV-2 pandemic season, where RSV circulation was almost absent, RSV infections presented with an increased and anticipated peak compared to pre-pandemic seasons. While mostly targeting infants below 1 year of age, there was a proportional increase in RSV infections and hospitalizations in older age groups in the post-pandemic period. A forecasting model built using RSV weekly data from 2018 to 2022 predicted the RSV peaks of 2023, showing a reasonable level of accuracy (MAPE 33%). Additional analysis indicated that the peak of RSV cases is expected to be reached after 4-5 weeks from case doubling.

Conclusion: Our study provides epidemiological evidence on the dynamics of RSV circulation before and after the COVID-19 pandemic. Our findings highlight the potential of combining surveillance and forecasting to promote preparedness for the next RSV epidemics.

Citing Articles

Analysis and prediction of the incidence temporal trends of echinococcosis in China from 2010 to 2021.

Ai J, Zheng J, Zhu C, Bai Y, Shi J, Zhang K Sci Rep. 2025; 15(1):6423.

PMID: 39984565 PMC: 11845582. DOI: 10.1038/s41598-025-90207-9.

Reassessing the Risk of Severe Parvovirus B19 Infection in the Immunocompetent Population: A Call for Vigilance in the Wake of Resurgence.

Ceccarelli G, Branda F, Ciccozzi A, Romano C, Sanna D, Casu M Viruses. 2024; 16(9).

PMID: 39339829 PMC: 11435993. DOI: 10.3390/v16091352.

References

Hanson K, Azar M, Banerjee R, Chou A, Colgrove R, Ginocchio C . Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA's Diagnostics Committee. Clin Infect Dis. 2020; 71(10):2744-2751. PMC: 7454374. DOI: 10.1093/cid/ciaa508. View

Baker R, Park S, Yang W, Vecchi G, Metcalf C, Grenfell B . The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci U S A. 2020; 117(48):30547-30553. PMC: 7720203. DOI: 10.1073/pnas.2013182117. View

Weisman L . Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditions. Pediatr Infect Dis J. 2003; 22(2 Suppl):S33-7; discussion S37-9. DOI: 10.1097/01.inf.0000053883.08663.e5. View

Cardenas J, Pringle C, Filipp S, Gurka M, Ryan K, Avery K . Changes in Critical Bronchiolitis After COVID-19 Lockdown. Cureus. 2022; 14(5):e25064. PMC: 9203253. DOI: 10.7759/cureus.25064. View

Peri F, Lorenzon B, Cason C, Amaddeo A, Norbedo S, Comar M . Urgent Hospitalizations Related to Viral Respiratory Disease in Children during Autumn and Winter Seasons 2022/2023. Viruses. 2023; 15(12). PMC: 10748011. DOI: 10.3390/v15122425. View

Ciarlitto C, Vittucci A, Antilici L, Concato C, Di Camillo C, Zangari P . Respiratory Syncityal Virus A and B: three bronchiolitis seasons in a third level hospital in Italy. Ital J Pediatr. 2019; 45(1):115. PMC: 6712785. DOI: 10.1186/s13052-019-0704-0. View

Collins P, Fearns R, Graham B . Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease. Curr Top Microbiol Immunol. 2013; 372:3-38. PMC: 4794264. DOI: 10.1007/978-3-642-38919-1_1. View

Di Mattia G, Nenna R, Mancino E, Rizzo V, Pierangeli A, Villani A . During the COVID-19 pandemic where has respiratory syncytial virus gone?. Pediatr Pulmonol. 2021; 56(10):3106-3109. PMC: 8441855. DOI: 10.1002/ppul.25582. View

Paes B, Mitchell I, Banerji A, Lanctot K, Langley J . A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice. Can Respir J. 2011; 18(2):e10-9. PMC: 3084427. DOI: 10.1155/2011/493056. View

10.

Van Brusselen D, De Troeyer K, Ter Haar E, Vander Auwera A, Poschet K, Van Nuijs S . Bronchiolitis in COVID-19 times: a nearly absent disease?. Eur J Pediatr. 2021; 180(6):1969-1973. PMC: 7847293. DOI: 10.1007/s00431-021-03968-6. View

11.

Berbers G, Mollema L, van der Klis F, Den Hartog G, Schepp R . Antibody Responses to Respiratory Syncytial Virus: A Cross-Sectional Serosurveillance Study in the Dutch Population Focusing on Infants Younger Than 2 Years. J Infect Dis. 2020; 224(2):269-278. PMC: 8280491. DOI: 10.1093/infdis/jiaa483. View

12.

Zheng Z, Pitzer V, Shapiro E, Bont L, Weinberger D . Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US. JAMA Netw Open. 2021; 4(12):e2141779. PMC: 8678706. DOI: 10.1001/jamanetworkopen.2021.41779. View

13.

Azzari C, Baraldi E, Bonanni P, Bozzola E, Coscia A, Lanari M . Epidemiology and prevention of respiratory syncytial virus infections in children in Italy. Ital J Pediatr. 2021; 47(1):198. PMC: 8487331. DOI: 10.1186/s13052-021-01148-8. View

14.

Falsey A, Walsh E . Respiratory syncytial virus infection in elderly adults. Drugs Aging. 2005; 22(7):577-87. PMC: 7099998. DOI: 10.2165/00002512-200522070-00004. View

15.

Abraha H, Lanctot K, Paes B . Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention. Expert Rev Respir Med. 2015; 9(6):779-99. DOI: 10.1586/17476348.2015.1098536. View

16.

van Summeren J, Meijer A, Aspelund G, Casalegno J, Erna G, Hoang U . Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter?. Euro Surveill. 2021; 26(29). PMC: 8299745. DOI: 10.2807/1560-7917.ES.2021.26.29.2100639. View

17.

Broberg E, Waris M, Johansen K, Snacken R, Penttinen P . Seasonality and geographical spread of respiratory syncytial virus epidemics in 15 European countries, 2010 to 2016. Euro Surveill. 2018; 23(5). PMC: 5801642. DOI: 10.2807/1560-7917.ES.2018.23.5.17-00284. View

18.

Barbati F, Moriondo M, Pisano L, Calistri E, Lodi L, Ricci S . Epidemiology of Respiratory Syncytial Virus-Related Hospitalization Over a 5-Year Period in Italy: Evaluation of Seasonality and Age Distribution Before Vaccine Introduction. Vaccines (Basel). 2020; 8(1). PMC: 7157234. DOI: 10.3390/vaccines8010015. View

19.

Sherman A, Babiker A, Sieben A, Pyden A, Steinberg J, Kraft C . The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of 2 Large Metropolitan Centers in the United States. Clin Infect Dis. 2020; 72(5):e154-e157. PMC: 7717225. DOI: 10.1093/cid/ciaa1704. View

20.

Curatola A, Lazzareschi I, Bersani G, Covino M, Gatto A, Chiaretti A . Impact of COVID-19 outbreak in acute bronchiolitis: Lesson from a tertiary Italian Emergency Department. Pediatr Pulmonol. 2021; 56(8):2484-2488. PMC: 8242382. DOI: 10.1002/ppul.25442. View